| Model Number |
BBAP40 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/06/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that the affinity centrifugal blood pump exhibited clotting and flow issues.The issue was observed in the top part of the cone, with the issue worsening over time.The patient was on extracorporeal membrane oxygenation (ecmo) for 82 days and had been using this bio-pump for 8 days.Anticoagulant therapy with bivalirudin was administered, and anti-coagulation was assessed using act and partial thromboplastin time (ptt), which were documented on the patient chart.The priming solution used was saline, and no air entered the reservoir related to table manners.Protamine was not used as this was an ecmo case.The clot/fibrin growth occurred suddenly, and there was no venous reservoir as this was an ecmo case.The pump was not used in an ap40ast and no clamped lines were present in the circuit.The device was replaced to complete the case.There were no reported adverse patient effects because of the issue.Medtronic received additional information that the patient's temperature was 36 to 37.2.The pco2 (partial pressure of carbon dioxide) and po2 (partial pressure of oxygen) was 35mmhg and 381mmhg post oxygenator, respectively.Sweep was reduced from 7l/min to 6l/min.
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation: visual inspection shows evidence of a clot around the upper pivot.Visual inspection shows the impeller is loose inside the housing with evidence of damage to the upper pivot.The device was tested per specification.The device was run on a bio console from 0-4000 rpm¿s, using fluid, a noise level greater than 70 db was recorded, the specification is less than 68 db there was a flow of 7 lpm at 4000 rpm.Reason for the return was confirmed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information a 3a.Sex: this field was added.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|